HPR21 Project Orbis the UK: 18-Month Report Card – Implications of UK Market Access for Oncology Drugs Prior to Europe

Abstract

Authors

R Macaulay

Full Text Cite This Article
Back to Volume 25, Supplemental Issue 12S
Your browser is out-of-date

ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now

×